Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX

被引：0
|
作者：
Rothschild, C. [1 ]
Trossaert, M. [2 ]
Claeyssens, S. [3 ]
Lambert, T. [4 ]
Hassoun, A. [5 ]
Volot, F. [6 ]
Dubanchet, A. [7 ]
机构：
[1] Necker AP HP Hosp, Hemophilia Treatment Ctr, Paris, France
[2] Hop Hotel Dieu, Hemophilia Treatment Ctr, Nantes, France
[3] Purpan Hosp, Hemophilia Treatment Ctr, Toulouse, France
[4] Bicetre AP HP Hosp, Hemophilia Treatment Ctr, Le Kremlin Bicetre, France
[5] Simone Veil Hosp, Hemophilia Treatment Ctr, Montmorency Foret, France
[6] Bocage Hosp, Hemophilia Treatment Ctr, Dijon, France
[7] Pfizer, Paris, France
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [21] Impact of Age and Type of Underlying Disease on Long-Term Safety and Efficacy in Patients with Transfusional Hemosiderosis Treated with Deferasirox: Results from a 3-Year Non-Interventional Study (SENTINEL)
    Elalfy, Mohsen
    Inusa, Baba
    Beneitez, David
    Xicoy, Blanca
    Nieto, Maria Soledad Duran
    Bruederle, Andreas
    Azmon, Amin
    El-Beshlawy, Amal
    BLOOD, 2016, 128 (22)
  • [22] Four-Year Results from PATRO Children, a Multi-Centre, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment
    Pfaffle, Roland
    Kanumakala, Shankar
    Charlotte, Hoybye
    Berit, Kristrom
    Markus, Zabransky
    Tadej, Battelino
    Michel, Colle
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 379 - 379
  • [23] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [24] Golimumab in real-world practice in patients with ulcerative colitis: 2-year interim results from a non-interventional trial in Germany
    Teich, N.
    Gruemmer, H.
    Joergensen, E.
    Liceni, T.
    Holtkamp-Endemann, W.
    Cornillie, F.
    Hohenberger, S.
    Fischer, T.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S338 - S338
  • [25] Long-term safety and efficacy of risperidone in children with disruptive behaviour disordersResults of a 2-year extension study
    Magali Reyes
    Roza Olah
    Krisztina Csaba
    Ilse Augustyns
    Marielle Eerdekens
    European Child & Adolescent Psychiatry, 2006, 15 : 97 - 104
  • [26] Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: interim analysis of a 2-year extension study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S368 - S369
  • [27] Long-Term Treatment of chronic schizophrenic Patients with Flupentixol decanoate Results of a prospective non-interventional Study
    Laux, Gerd
    Steinmann, Carsten
    Glaser, Thomas
    PSYCHOPHARMAKOTHERAPIE, 2010, 17 (06): : 274 - +
  • [28] Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study
    Spiekerkoetter, Ute
    Couce, Maria L.
    Das, Anibh M.
    de Laet, Corinne
    Dionisi-Vici, Carlo
    Lund, Allan M.
    Schiff, Manuel
    Spada, Marco
    Sparve, Erik
    Szamosi, Johan
    Vara, Roshni
    Rudebeck, Mattias
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (07): : 427 - 435
  • [29] Long-term safety and efficacy of Clobazam for Lennox Gastaut syndrome (LGS): 2-year results of an open label extension (OLE) study
    Ng, Y. T.
    Conry, J. A.
    Paolicchi, J. M.
    Kernitsky, L.
    Mitchell, W. G.
    Drummond, R.
    Austin, S. A.
    Weinberg, M. A.
    Owen, J. R.
    ANNALS OF NEUROLOGY, 2011, 70 : S140 - S140
  • [30] Safety and clinical efficacy outcomes from the Long-term extension study of tolebrutinib in patients with relapsing multiple sclerosis: 2-year results
    Oh, J.
    Syed, S.
    Orogun, L.
    Xu, Z.
    Turner, T. J.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 342 - 343
12345